Literature DB >> 24136096

Chemical safety, health care costs and the Affordable Care Act.

Philip J Landrigan1, Lynn R Goldman.   

Abstract

On May 22, 2013, the late Senator Frank Lautenberg (D-NJ), Senator David Vitter (R-LA) and 19 of their colleagues introduced bipartisan chemical safety legislation in the US Senate, "The Chemical Safety Improvement Act of 2013." The bill's purpose is to protect human health and the environment against the hazards of toxic chemicals, by requiring the US Environmental Protection Agency (EPA) to examine the safety of all chemicals in consumer products. The bill is currently before the Senate Committee on Environment and Public Works, chaired by Senator Barbara Boxer (D-CA). This legislation is critically important for physicians and healthcare organizations because it creates significant new opportunities to prevent disease and cut healthcare costs.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Affordable Care Act; Health Costs; Safe Chemicals Act

Mesh:

Substances:

Year:  2013        PMID: 24136096     DOI: 10.1002/ajim.22268

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  6 in total

1.  Building a robust 21st century chemical testing program at the U.S. Environmental Protection Agency: recommendations for strengthening scientific engagement.

Authors:  Jennifer McPartland; Heather C Dantzker; Christopher J Portier
Journal:  Environ Health Perspect       Date:  2014-10-24       Impact factor: 9.031

2.  Biochemical strategies for the detection and detoxification of toxic chemicals in the environment.

Authors:  Ferdinando Febbraio
Journal:  World J Biol Chem       Date:  2017-02-26

3.  Population susceptibility: A vital consideration in chemical risk evaluation under the Lautenberg Toxic Substances Control Act.

Authors:  Patricia D Koman; Veena Singla; Juleen Lam; Tracey J Woodruff
Journal:  PLoS Biol       Date:  2019-08-29       Impact factor: 8.029

4.  Determination of Picomolar Concentrations of Paraoxon in Human Urine by Fluorescence-Based Enzymatic Assay.

Authors:  Giovanni Paolo Cetrangolo; Carla Gori; Janis Rusko; Sara Terreri; Giuseppe Manco; Amelia Cimmino; Ferdinando Febbraio
Journal:  Sensors (Basel)       Date:  2019-11-07       Impact factor: 3.576

5.  High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.

Authors:  Fabian Alexander Grimm; Yasuhiro Iwata; Oksana Sirenko; Michael Bittner; Ivan Rusyn
Journal:  Assay Drug Dev Technol       Date:  2015-11-05       Impact factor: 1.738

6.  Differential immunotoxicity induced by two different windows of developmental trichloroethylene exposure.

Authors:  Kathleen M Gilbert; William Woodruff; Sarah J Blossom
Journal:  Autoimmune Dis       Date:  2014-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.